{"total":68,"page":1,"pageSize":25,"pages":3,"millis":0,"query":{"q":"","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"2020-03-24","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-036","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-036","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-036"},{"id":"AGY-FED-HEALTH-OTHER-042","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-042","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-042"},{"id":"AGY-FED-HEALTH-OTHER-049","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021)","title":"Letter of Authorization, Imported Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (reissued Mar. 24, 2021)","dateIssued":"2021-03-24","startDate":"2020-03-24","endDate":"2021-07-06","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-049","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-049"},{"id":"AGY-FED-HEALTH-OTHER-051","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020)","title":"Letter of Authorization to Manufacturers and Other Stakeholders: Ventilators","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-051","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-051"},{"id":"AGY-FED-HEALTH-OTHER-011","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency","title":"DEA State Reciprocity (final) (Signed)","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-011","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-011"},{"id":"AGY-FED-HEALTH-OTHER-044","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)","title":"Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2023-09-05","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","MASK","OTHER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-044","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-044"},{"id":"AGY-FED-HEALTH-OTHER-131","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Process for Making Available Guidance Documents Related to Coronavirus Disease 2019, 85 Fed. Reg. 16949 (Mar. 25, 2020)","title":"Process for Making Available Guidance Documents Related to Coronavirus Disease 2019","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-131","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-131"},{"id":"AGY-FED-HEALTH-OTHER-045","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-045","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-045"},{"id":"AGY-FED-HEALTH-OTHER-075","kind":"context","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Michael Carvajal, Director, Federal Bureau of Prisons","instrument":"Statement from BOP Director on the BOP response to the COVID-19 pandemic (Mar. 26, 2020) (Phase Four measures: screening, quarantine of new admissions, modified operations)","title":"Statement from BOP Director: BOP response to COVID-19 pandemic","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2020-04-01","quarters":["2020Q2"],"types":["QUAR","EMP","GATH"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-075","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-075"},{"id":"AGY-FED-HEALTH-OTHER-081","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Justice, Office of the Attorney General","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William P. Barr, Attorney General","instrument":"Memorandum for Director of Bureau of Prisons, Prioritization of Home Confinement As Appropriate in Response to COVID-19 Pandemic (Mar. 26, 2020)","title":"Prioritization of Home Confinement As Appropriate in Response to COVID-19 Pandemic","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2020-04-03","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-081","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-081"},{"id":"AGY-FED-HEALTH-OTHER-013","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-021 (DEA073), letter to practitioner registrants and pharmacists announcing temporary exceptions for oral schedule II prescriptions in emergency situations during the COVID-19 emergency","title":"Oral CII for regular CII script (Final)","dateIssued":"2020-03-27","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-013","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-013"},{"id":"AGY-FED-HEALTH-OTHER-037","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (drugs and biological products), 85 Fed. Reg. 18250 (Apr. 1, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-27","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-037","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-037"},{"id":"AGY-FED-HEALTH-OTHER-066","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs, Veterans Health Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs","instrument":"VA announcement of Mar. 27, 2020 releasing the VHA COVID-19 Response Plan: elective and non-emergent procedures postponed; outpatient care shifted to telehealth","title":"VA Releases COVID-19 Response Plan","dateIssued":"2020-03-27","startDate":"2020-03-27","endDate":"2020-06-30","quarters":["2020Q2"],"types":["HC","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-066","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-066"},{"id":"AGY-FED-HEALTH-OTHER-050","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA (letter to Battelle Memorial Institute)","instrument":"Emergency Use Authorization: Battelle Critical Care Decontamination System for decontaminating compatible N95 respirators (issued Mar. 28, 2020; reissued Jan. 21, 2021; revoked June 30, 2021)","title":"Letter of Authorization, Battelle CCDS Critical Care Decontamination System (reissued Jan. 21, 2021)","dateIssued":"2021-01-21","startDate":"2020-03-28","endDate":"2021-06-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-050","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-050"},{"id":"AGY-FED-HEALTH-OTHER-058","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Indian Health Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Indian Health Service (Principal Deputy Director Rear Adm. Michael D. Weahkee)","instrument":"IHS Coronavirus (COVID-19) News page listing the Tribal and Urban Indian Organization Leader letters of Mar. 9, 16, 23 and 27, 2020 (archived Mar. 29, 2020)","title":"Coronavirus (COVID-19) / News: Tribal and Urban Indian Organization Leader Messages on COVID-19","dateIssued":"2020-03-29","startDate":"2020-03-29","endDate":"2020-06-30","quarters":["2020Q2"],"types":["HC","EMER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-058","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-058"},{"id":"AGY-FED-HEALTH-OTHER-028","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment","instrument":"OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020)","title":"OTP Guidance for Patients Quarantined at Home with the Coronavirus","dateIssued":"2020-03-30","startDate":"2020-03-30","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","QUAR","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-028","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-028"},{"id":"AGY-FED-HEALTH-OTHER-014","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division (with SAMHSA)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-022 (DEA068), letter permitting DATA-waived practitioners to prescribe buprenorphine to new patients on the basis of a telephone evaluation during the COVID-19 emergency","title":"DEA/SAMHSA Buprenorphine Telemedicine (Final)","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-014","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-014"},{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015"},{"id":"AGY-FED-HEALTH-OTHER-046","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency (Apr. 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency","dateIssued":"2020-04-01","startDate":"2020-04-01","endDate":"2023-11-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-046","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-046"},{"id":"AGY-FED-HEALTH-OTHER-073","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Director, Federal Bureau of Prisons","instrument":"COVID-19 Action Plan: Phase Five (ordered Mar. 31, 2020; effective Apr. 1, 2020): inmates secured in assigned cells/quarters for 14 days; quarantine of new admissions","title":"COVID-19 Action Plan: Phase Five - Additional Agency-wide Actions Effective April 1","dateIssued":"2020-03-31","startDate":"2020-04-01","endDate":"2020-05-18","quarters":["2020Q2"],"types":["QUAR","GATH","CLOSE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-073","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-073"},{"id":"AGY-FED-HEALTH-OTHER-002","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19, 85 Fed. Reg. 19392 (Apr. 7, 2020)","title":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19","dateIssued":"2020-04-02","startDate":"2020-04-02","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-002","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-002"},{"id":"AGY-FED-HEALTH-OTHER-082","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Justice, Office of the Attorney General","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William P. Barr, Attorney General","instrument":"Memorandum for Director of Bureau of Prisons, Increasing Use of Home Confinement at Institutions Most Affected by COVID-19 (Apr. 3, 2020)","title":"Increasing Use of Home Confinement at Institutions Most Affected by COVID-19","dateIssued":"2020-04-03","startDate":"2020-04-03","endDate":"2023-05-10","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-082","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-082"},{"id":"AGY-FED-HEALTH-OTHER-076","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Federal Bureau of Prisons","instrument":"Update on COVID-19 and Home Confinement (Apr. 5, 2020)","title":"Update on COVID-19 and Home Confinement: BOP continuing to aggressively screen potential inmates","dateIssued":"2020-04-05","startDate":"2020-04-05","endDate":"2020-06-30","quarters":["2020Q2"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-076","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-076"},{"id":"AGY-FED-HEALTH-OTHER-016","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration","title":"Off-site OTP delivery method (Final)","dateIssued":"2020-04-07","startDate":"2020-04-07","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-016","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-016"},{"id":"AGY-FED-HEALTH-OTHER-003","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)","title":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-04-09","startDate":"2020-04-09","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-003","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-003"}],"facets":{"kind":[{"value":"order","label":"Order","count":55},{"value":"context","label":"Context (guidance or announcement)","count":13}],"level":[{"value":"federal","label":"Federal","count":68}],"state":[],"type":[{"value":"OTHER","label":"Other","count":42},{"value":"HC","label":"Health care orders","count":38},{"value":"SUPPLY","label":"Supply chain","count":17},{"value":"TELE","label":"Telework mandate","count":11},{"value":"GATH","label":"Gathering cap","count":6},{"value":"SCH","label":"Schools and child care","count":6},{"value":"EMER","label":"Emergency declaration","count":5},{"value":"QUAR","label":"Quarantine and isolation","count":5},{"value":"EMP","label":"Workplace rules","count":4},{"value":"MASK","label":"Face-covering requirement","count":4},{"value":"CLOSE","label":"Business closure","count":3},{"value":"VAX","label":"Vaccination or testing","count":3},{"value":"TRAV","label":"Travel and quarantine","count":2},{"value":"CAP","label":"Capacity limit","count":1},{"value":"CRT","label":"Courts and public offices","count":1}],"quarter":[{"value":"2021Q3","label":"2021 Q3","count":50},{"value":"2021Q1","label":"2021 Q1","count":44},{"value":"2021Q2","label":"2021 Q2","count":44},{"value":"2020Q4","label":"2020 Q4","count":43},{"value":"2020Q2","label":"2020 Q2","count":40},{"value":"2020Q3","label":"2020 Q3","count":40}],"grade":[{"value":"primary","label":"Primary source read","count":65},{"value":"secondary","label":"Confirmed from a secondary source","count":3}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":68}]}}